Drugs--Federal Drug Administration ban on Laetrile treatments for terminally ill cancer patients is arbitrary and capricious.
نویسنده
چکیده
This Casenote/Comment is brought to you for free and open access by TU Law Digital Commons. It has been accepted for inclusion in Tulsa Law Review by an authorized editor of TU Law Digital Commons. For more information, please contact [email protected]. Recommended Citation Terry H. Bitting, Drugs--Federal Drug Administration Ban on Laetrile Treatments for Terminally Ill Cancer Patients is Arbitrary and Capricious, 14 Tulsa L. J. 222 (2013).
منابع مشابه
A study in futility: Abigail Alliance for Better Access to Developmental Drugs will not expand access to experimental drugs for the terminally ill.
In 2008, it was estimated that 565,650 Americans would die of cancer, accounting for one of every four deaths in the United States. Doctors expected to diagnose 1,437,180 new patients with cancer throughout 2008, bringing the U.S. cancer population to over ten million. While many of the cancers diagnosed are curable or manageable, others continue to remain deadly. These terminally ill patients ...
متن کاملFDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
On December 14, 2006, the Food and Drug Administration (FDA) proposed two new regulations in the Federal Register amending current regulations governing expanded access to investigational drugs for treatment use and charging for investigational drugs. The proposals come at a time when FDA has found itself under new pressure to provide seriously ill patients with early access to investigational ...
متن کاملToward a New Consumer Protection
Consumer protection is everywhere in retreat. Congress has rejected the Food and Drug Administration's proposed ban on saccharin,' and several courts and state legislatures have attempted to block the FDA's attack on Laetrile.2 The Consumer Product Safety Commission's recent ruling that swimming pool slides must carry danger warnings 3 has elicited widespread ridicule, brought a reversal in the...
متن کاملPregabalin prescription for terminally ill cancer patients receiving specialist palliative care in an acute hospital
BACKGROUND Pregabalin is recommended as an adjuvant analgesic for neuropathic cancer-related pain, and may be taken at all steps of the World Health Organization analgesic ladder. However, unlike opioids, pregabalin treatments are limited to an oral administration route. If patients have oral feeding difficulties, it is not possible to administer any drug as an adjuvant analgesic for neuropathi...
متن کاملThe ethics of phase 0 oncology trials.
Recent guidance from the Food and Drug Administration supports the conduct of a new type of exploratory clinical trial, commonly called phase 0 clinical trials. Proponents argue that phase 0 clinical trials have the potential to expedite the development of new oncology drugs while exposing fewer research subjects to the risks of experimental treatments. At the same time, phase 0 oncology trials...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Tulsa law journal
دوره 14 شماره
صفحات -
تاریخ انتشار 1978